Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Water and Sudafed in Autonomic Failure
NCT02149901Phase 1Terminated
- Sponsor
- Vanderbilt University
- Start
- Oct 2014
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pseudoephedrine in Neurogenic Orthostatic Hypotension (nOH) (4 arms), sponsored by Vanderbilt University. Primary endpoint: Peak increase in systolic blood pressure relative to baseline. Started Oct 2014; status: terminated.
02
Drugs
pseudoephedrine
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT02149901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02149901.